Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Piñeros Nieto, Diego Alejandro"'
Introducción. La estenosis biliar post-trasplante hepático es una complicación incidente y el manejo percutáneo transhepático es una opción terapéutica. El objetivo de este estudio fue describir los desenlaces del programa de bilioplastía ser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2303820bb41822dfc3ebcf252b941649
Publikováno v:
Organization WH. International Agency for Research on Cancer.
American Cancer Society.
Elsayes KM, Hooker JC, Agrons MM, Kielar AZ, Tang A, Fowler KJ, et al. 2017 Version of LI-RADS for CT and MR Imaging: An Update. RadioGraphics [Internet]. 2017 Nov 13 [cited 2020 Jun 1];37(7):1994–2017. Available from: http://pubs.rsna.org/doi/10.1148/rg.2017170098
MC N, I S, A C, D U, WA R, F C-M, et al. Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas From Colombia. Hepat Res Treat [Internet]. 2011 [cited 2020 Jun 11];2011. Available from: https://pubmed.ncbi.nlm.nih.gov/22114738/
El-Serag HB, Rudolph KL. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis. Gastroenterology. 2007;132(7):2557–76.
Feng K, Yan J, Li X, Xia F, Ma K, Wang S, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol [Internet]. 2012;57(4):794–802. Available from: http://dx.doi.org/10.1016/j.jhep.2012.05.007
Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology [Internet]. 2008 Jan [cited 2020 May 30];47(1):82–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18008357
McDermott S, Gervais DA. Radiofrequency ablation of liver tumors. Semin Intervent Radiol. 2013;30(1):49–55.
Ziemlewicz TJ, Wells SA, Lubner MG, Brace CL, Lee FT, Hinshaw JL. Hepatic Tumor Ablation. Surg Clin North Am. 2016;96(2):315–39.
Lau WY, Lai ECH. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg [Internet]. 2009;249(1):20–5. Available from: papers3://publication/doi/10.1097/SLA.0b013e31818eec29
Luming Chen JS, Yang X. Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status. Cancer Lett. 2016;33(4):78–84.
HALSTED WS. The Results of Operations for the Cure of Cancer of the Breast Performed At the Johns Hopkins Hospital From June, 1889, To January, 1894. Ann Surg. 1894;20:497–555.
Rossi S, Fornari F, Buscarini L. Percutaneous ultrasound-guided radiofrequency electrocautery for the treatment of small hepatocellular carcinoma. J Interv Radiol. 1993;8(3):97–103.
Koda M, Murawaki Y, Hirooka Y, Kitamoto M, Ono M, Sakaeda H, et al. Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16346 treated nodules in 13283 patients. Hepatol Res. 2012;42(11):1058–64.
A F, R V, C A, L B, M S, JR A, et al. Diagnosis of Hepatic Nodules 20 Mm or Smaller in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma. Hepatology [Internet]. 2008 [cited 2020 Jun 12];47(1). Available from: https://pubmed.ncbi.nlm.nih.gov/18069697/
K K, TK K, HJ J, MA H, L K, M G, et al. Optimization of Imaging Diagnosis of 1-2 Cm Hepatocellular Carcinoma: An Analysis of Diagnostic Performance and Resource Utilization. J Hepatol [Internet]. 2011 [cited 2020 Jun 12];54(4). Available from: https://pubmed.ncbi.nlm.nih.gov/21156219/
Bashir MR, Do Memorial RK, Kettering S, Center C, Fowler KJ, San UC, et al. LI-RADS ® v2018 CT/MRI Manual The LI-RADS ® v2018 Manual Writing Group Members Writing Group Members-in-Training [Internet]. [cited 2020 Jun 12]. Available from: https://www.acr.org/-/media/ACR/Files/Clinical-Resources/LIRADS/LI-RADS-2018-Manual-5Dec18.pdf?la=en
Ronot M, Vilgrain V. Hepatocellular carcinoma: Diagnostic criteria by imaging techniques. Vol. 28, Best Practice and Research: Clinical Gastroenterology. 2014. p. 795–812.
R L, JM L. Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma. Semin Liver Dis [Internet]. 2010 [cited 2020 Jun 12];30(1). Available from: https://pubmed.ncbi.nlm.nih.gov/20175033/
Kielar A, Fowler KJ, Lewis S, Yaghmai V, Miller FH, Yarmohammadi H, et al. Locoregional Therapies for Hepatocellular Carcinoma and the New LI-RADS Treatment Response Algorithm. Abdom Radiol (New York) [Internet]. 2018 [cited 2020 Jun 12];43(1):218. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771991/
Zheng S-G, Xu H-X, Liu L-N. Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound. World J Radiol. 2014;6(1):7–14.
Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012;107(4):569–77; quiz 578.
Bouda D, Lagadec M, Alba CG, Barrau V, Burgio MD, Moussa N, et al. Imaging review of hepatocellular carcinoma after thermal ablation: The good, the bad, and the ugly. J Magn Reson Imaging. 2016;44(5):1070–90.
Koda M, Tokunaga S, Miyoshi K, Kishina M, Fujise Y, Kato J, et al. Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma. Eur J Radiol. 2012;81(10):2730–6.
Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet [Internet]. 2018 Mar 31 [cited 2020 Jun 11];391(10127):1301–14. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30010-2/fulltext
Ruzzenente A, De Angelis M, Conci S, Campagnaro T, Isa G, Bagante F, et al. The albumin-bilirubin score stratifies the outcomes of Child-Pugh class A patients after resection of hepatocellular carcinoma. Transl Cancer Res [Internet]. 2018 [cited 2020 Jun 12];8(3):S233–44. Available from: http://tcr.amegroups.com/article/view/26077
IS O, DH S, TW K, MW L, W K, GY G, et al. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients With Very Early-Stage Hepatocellular Carcinoma Treated With Radiofrequency Ablation. Dig Dis Sci [Internet]. 2017 [cited 2020 Jun 12];62(11). Available from: https://pubmed.ncbi.nlm.nih.gov/28983724/
Chen P-C, Chiu N-C, Su C-W, Huang Y-H, Hou M-C, Lin H-C, et al. Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy. www.ejcma.org J Chin Med Assoc [Internet]. 2019 [cited 2020 Jun 12]; Available from: www.ejcma.org
Ni J-Y, An C, Zhang T-Q, Huang Z-M, Jiang X-Y, Huang J-H. Predictive value of the albumin-bilirubin grade on long-term outcomes of CT-guided percutaneous microwave ablation in intrahepatic cholangiocarcinoma. Int J Hyperth [Internet]. 2019 Jan 1 [cited 2020 Jun 12];36(1):327–35. Available from: https://www.tandfonline.com/doi/full/10.1080/02656736.2019.1567834
Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 2010;252(6):903–12.
Qi X, Tang Y, An D, Bai M, Shi X, Wang J, et al. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: a meta-analysis of randomized controlled trials. J Clin Gastroenterol. 2014;48(5):450–7.
Chok KS, Ng KK, Poon RTP, Lam CM, Yuen J, Tso WK, et al. Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization. Arch Surg. 2006;141(12):1231–6.
Nouso K, Kariyama K, Nakamura S, Oonishi A, Wakuta A, Oyama A, et al. Application of Radiofrequency Ablation for the Treatment of Intermediate-Stage Hepatocellular Carcinoma. J Gastroenterol Hepatol [Internet]. 2016;(January 2001):695–700. Available from: http://doi.wiley.com/10.1111/jgh.13586
Murakami T, Ishimaru H, Sakamoto I, Uetani M, Matsuoka Y, Daikoku M, et al. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: Rate and risk factors for local recurrence. Cardiovasc Intervent Radiol. 2007;30(4):696–704.
V M, E R, R D, S A, A P, F B, et al. Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients With Cirrhosis. N Engl J Med [Internet]. 1996 [cited 2020 Jun 11];334(11). Available from: https://pubmed.ncbi.nlm.nih.gov/8594428/
Kim JH, Won HJ, Shin YM, Kim K-A, Kim PN. Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma. AJR Am J Roentgenol. 2011;196(2):W205–9.
Oshowo A, Gillams A, Harrison E, Lees WR, Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg. 2003;90(10):1240–3.
Nieto IS de, Santaolaya M. Ablación por radiofrecuencia de los tumores hepáticos primarios y secundarios. An médicos. 2013;58(3):163–8.
Pugh RNH, Murray???Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–9.
JM L, R L. mRECIST for HCC: Performance and Novel Refinements. J Hepatol [Internet]. 2020 [cited 2020 Jun 12];72(2). Available from: https://pubmed.ncbi.nlm.nih.gov/31954493/
IBM. IBM SPSS Statistics for Macintosh. Armonk, NY: IBM Corp: IBM Corp; 2013.
Ding J, Jing X, Wang Y, Wang F, Wang Y, Du Z. Thermal ablation for hepatocellular carcinoma: a large-scale analysis of long-term outcome and prognostic factors. Clin Radiol. 2016;71(12):1270–6.
Zheng RN, You ZJ, Lin SH, Jia J, Cai YM, Liu C, et al. Efficacy of percutaneous radiofrequency ablation for the treatment of hepatocellular carcinoma. Genet Mol Res. 2015;14(4):17982–94.
DJ P, R S, E A, C Y, T A, K K, et al. The ALBI Grade Provides Objective Hepatic Reserve Estimation Across Each BCLC Stage of Hepatocellular Carcinoma. J Hepatol [Internet]. 2017 [cited 2020 Jun 13];66(2). Available from: https://pubmed.ncbi.nlm.nih.gov/27677714/?dopt=Abstract
Hiraoka A, Kumada T, Kudo M, Hirooka M, Tsuji K, Itobayashi E, et al. Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications. Liver Cancer [Internet]. 2017 [cited 2020 Jun 13];6(3):204. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473065/
Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S, et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transplant [Internet]. 2005 Sep 1 [cited 2020 Jun 13];11(9):1117–26. Available from: http://doi.wiley.com/10.1002/lt.20469
Glassberg MB, Ghosh S, Clymer JW, Qadeer RA, Ferko NC, Sadeghirad B, et al. Microwave ablation compared with radiofrequency ablation for treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis. Onco Targets Ther [Internet]. 2019 [cited 2020 May 26];12:6407–38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31496742
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
American Cancer Society.
Elsayes KM, Hooker JC, Agrons MM, Kielar AZ, Tang A, Fowler KJ, et al. 2017 Version of LI-RADS for CT and MR Imaging: An Update. RadioGraphics [Internet]. 2017 Nov 13 [cited 2020 Jun 1];37(7):1994–2017. Available from: http://pubs.rsna.org/doi/10.1148/rg.2017170098
MC N, I S, A C, D U, WA R, F C-M, et al. Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas From Colombia. Hepat Res Treat [Internet]. 2011 [cited 2020 Jun 11];2011. Available from: https://pubmed.ncbi.nlm.nih.gov/22114738/
El-Serag HB, Rudolph KL. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis. Gastroenterology. 2007;132(7):2557–76.
Feng K, Yan J, Li X, Xia F, Ma K, Wang S, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol [Internet]. 2012;57(4):794–802. Available from: http://dx.doi.org/10.1016/j.jhep.2012.05.007
Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology [Internet]. 2008 Jan [cited 2020 May 30];47(1):82–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18008357
McDermott S, Gervais DA. Radiofrequency ablation of liver tumors. Semin Intervent Radiol. 2013;30(1):49–55.
Ziemlewicz TJ, Wells SA, Lubner MG, Brace CL, Lee FT, Hinshaw JL. Hepatic Tumor Ablation. Surg Clin North Am. 2016;96(2):315–39.
Lau WY, Lai ECH. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg [Internet]. 2009;249(1):20–5. Available from: papers3://publication/doi/10.1097/SLA.0b013e31818eec29
Luming Chen JS, Yang X. Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status. Cancer Lett. 2016;33(4):78–84.
HALSTED WS. The Results of Operations for the Cure of Cancer of the Breast Performed At the Johns Hopkins Hospital From June, 1889, To January, 1894. Ann Surg. 1894;20:497–555.
Rossi S, Fornari F, Buscarini L. Percutaneous ultrasound-guided radiofrequency electrocautery for the treatment of small hepatocellular carcinoma. J Interv Radiol. 1993;8(3):97–103.
Koda M, Murawaki Y, Hirooka Y, Kitamoto M, Ono M, Sakaeda H, et al. Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16346 treated nodules in 13283 patients. Hepatol Res. 2012;42(11):1058–64.
A F, R V, C A, L B, M S, JR A, et al. Diagnosis of Hepatic Nodules 20 Mm or Smaller in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma. Hepatology [Internet]. 2008 [cited 2020 Jun 12];47(1). Available from: https://pubmed.ncbi.nlm.nih.gov/18069697/
K K, TK K, HJ J, MA H, L K, M G, et al. Optimization of Imaging Diagnosis of 1-2 Cm Hepatocellular Carcinoma: An Analysis of Diagnostic Performance and Resource Utilization. J Hepatol [Internet]. 2011 [cited 2020 Jun 12];54(4). Available from: https://pubmed.ncbi.nlm.nih.gov/21156219/
Bashir MR, Do Memorial RK, Kettering S, Center C, Fowler KJ, San UC, et al. LI-RADS ® v2018 CT/MRI Manual The LI-RADS ® v2018 Manual Writing Group Members Writing Group Members-in-Training [Internet]. [cited 2020 Jun 12]. Available from: https://www.acr.org/-/media/ACR/Files/Clinical-Resources/LIRADS/LI-RADS-2018-Manual-5Dec18.pdf?la=en
Ronot M, Vilgrain V. Hepatocellular carcinoma: Diagnostic criteria by imaging techniques. Vol. 28, Best Practice and Research: Clinical Gastroenterology. 2014. p. 795–812.
R L, JM L. Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma. Semin Liver Dis [Internet]. 2010 [cited 2020 Jun 12];30(1). Available from: https://pubmed.ncbi.nlm.nih.gov/20175033/
Kielar A, Fowler KJ, Lewis S, Yaghmai V, Miller FH, Yarmohammadi H, et al. Locoregional Therapies for Hepatocellular Carcinoma and the New LI-RADS Treatment Response Algorithm. Abdom Radiol (New York) [Internet]. 2018 [cited 2020 Jun 12];43(1):218. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771991/
Zheng S-G, Xu H-X, Liu L-N. Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound. World J Radiol. 2014;6(1):7–14.
Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012;107(4):569–77; quiz 578.
Bouda D, Lagadec M, Alba CG, Barrau V, Burgio MD, Moussa N, et al. Imaging review of hepatocellular carcinoma after thermal ablation: The good, the bad, and the ugly. J Magn Reson Imaging. 2016;44(5):1070–90.
Koda M, Tokunaga S, Miyoshi K, Kishina M, Fujise Y, Kato J, et al. Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma. Eur J Radiol. 2012;81(10):2730–6.
Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet [Internet]. 2018 Mar 31 [cited 2020 Jun 11];391(10127):1301–14. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30010-2/fulltext
Ruzzenente A, De Angelis M, Conci S, Campagnaro T, Isa G, Bagante F, et al. The albumin-bilirubin score stratifies the outcomes of Child-Pugh class A patients after resection of hepatocellular carcinoma. Transl Cancer Res [Internet]. 2018 [cited 2020 Jun 12];8(3):S233–44. Available from: http://tcr.amegroups.com/article/view/26077
IS O, DH S, TW K, MW L, W K, GY G, et al. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients With Very Early-Stage Hepatocellular Carcinoma Treated With Radiofrequency Ablation. Dig Dis Sci [Internet]. 2017 [cited 2020 Jun 12];62(11). Available from: https://pubmed.ncbi.nlm.nih.gov/28983724/
Chen P-C, Chiu N-C, Su C-W, Huang Y-H, Hou M-C, Lin H-C, et al. Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy. www.ejcma.org J Chin Med Assoc [Internet]. 2019 [cited 2020 Jun 12]; Available from: www.ejcma.org
Ni J-Y, An C, Zhang T-Q, Huang Z-M, Jiang X-Y, Huang J-H. Predictive value of the albumin-bilirubin grade on long-term outcomes of CT-guided percutaneous microwave ablation in intrahepatic cholangiocarcinoma. Int J Hyperth [Internet]. 2019 Jan 1 [cited 2020 Jun 12];36(1):327–35. Available from: https://www.tandfonline.com/doi/full/10.1080/02656736.2019.1567834
Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 2010;252(6):903–12.
Qi X, Tang Y, An D, Bai M, Shi X, Wang J, et al. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: a meta-analysis of randomized controlled trials. J Clin Gastroenterol. 2014;48(5):450–7.
Chok KS, Ng KK, Poon RTP, Lam CM, Yuen J, Tso WK, et al. Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization. Arch Surg. 2006;141(12):1231–6.
Nouso K, Kariyama K, Nakamura S, Oonishi A, Wakuta A, Oyama A, et al. Application of Radiofrequency Ablation for the Treatment of Intermediate-Stage Hepatocellular Carcinoma. J Gastroenterol Hepatol [Internet]. 2016;(January 2001):695–700. Available from: http://doi.wiley.com/10.1111/jgh.13586
Murakami T, Ishimaru H, Sakamoto I, Uetani M, Matsuoka Y, Daikoku M, et al. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: Rate and risk factors for local recurrence. Cardiovasc Intervent Radiol. 2007;30(4):696–704.
V M, E R, R D, S A, A P, F B, et al. Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients With Cirrhosis. N Engl J Med [Internet]. 1996 [cited 2020 Jun 11];334(11). Available from: https://pubmed.ncbi.nlm.nih.gov/8594428/
Kim JH, Won HJ, Shin YM, Kim K-A, Kim PN. Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma. AJR Am J Roentgenol. 2011;196(2):W205–9.
Oshowo A, Gillams A, Harrison E, Lees WR, Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg. 2003;90(10):1240–3.
Nieto IS de, Santaolaya M. Ablación por radiofrecuencia de los tumores hepáticos primarios y secundarios. An médicos. 2013;58(3):163–8.
Pugh RNH, Murray???Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–9.
JM L, R L. mRECIST for HCC: Performance and Novel Refinements. J Hepatol [Internet]. 2020 [cited 2020 Jun 12];72(2). Available from: https://pubmed.ncbi.nlm.nih.gov/31954493/
IBM. IBM SPSS Statistics for Macintosh. Armonk, NY: IBM Corp: IBM Corp; 2013.
Ding J, Jing X, Wang Y, Wang F, Wang Y, Du Z. Thermal ablation for hepatocellular carcinoma: a large-scale analysis of long-term outcome and prognostic factors. Clin Radiol. 2016;71(12):1270–6.
Zheng RN, You ZJ, Lin SH, Jia J, Cai YM, Liu C, et al. Efficacy of percutaneous radiofrequency ablation for the treatment of hepatocellular carcinoma. Genet Mol Res. 2015;14(4):17982–94.
DJ P, R S, E A, C Y, T A, K K, et al. The ALBI Grade Provides Objective Hepatic Reserve Estimation Across Each BCLC Stage of Hepatocellular Carcinoma. J Hepatol [Internet]. 2017 [cited 2020 Jun 13];66(2). Available from: https://pubmed.ncbi.nlm.nih.gov/27677714/?dopt=Abstract
Hiraoka A, Kumada T, Kudo M, Hirooka M, Tsuji K, Itobayashi E, et al. Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications. Liver Cancer [Internet]. 2017 [cited 2020 Jun 13];6(3):204. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473065/
Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S, et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transplant [Internet]. 2005 Sep 1 [cited 2020 Jun 13];11(9):1117–26. Available from: http://doi.wiley.com/10.1002/lt.20469
Glassberg MB, Ghosh S, Clymer JW, Qadeer RA, Ferko NC, Sadeghirad B, et al. Microwave ablation compared with radiofrequency ablation for treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis. Onco Targets Ther [Internet]. 2019 [cited 2020 May 26];12:6407–38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31496742
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: El carcinoma hepatocelular (CHC) tiene alta prevalencia y tasa de mortalidad a nivel mundial. El manejo de CHC pequeños con técnicas locorregionales guiadas por imágenes en pacientes candidatos a trasplante hepático, funciona de ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f56963204afbe5267b1c8cbe930fef9
https://repository.urosario.edu.co/handle/10336/26518
https://repository.urosario.edu.co/handle/10336/26518